Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through ERK Signaling Pathway

International Journal of Oncology- Greece

doi 10.3892/ijo.2015.2827

Full Text

Abstract

Available in

Date

Authors

Publisher

Spandidos Publications

Related search

Cinobufacini Inhibits Epithelial-Mesenchymal Transition of Human Hepatocellular Carcinoma Cells Through C-Met/Erk Signaling Pathway

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2018English

Cullin7 Promotes Epithelial‑mesenchymal Transition of Esophageal Carcinoma via the ERK‑SNAI2 Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

STYK1 Promotes Epithelial-Mesenchymal Transition and Tumor Metastasis in Human Hepatocellular Carcinoma Through MEK/ERK and PI3K/AKT Signaling

Scientific Reports
Multidisciplinary
2016English

Metadherin Promotes Hepatocellular Carcinoma Metastasis Through Induction of Epithelial-Mesenchymal Transition

Clinical Cancer Research
Cancer ResearchOncology
2011English

Lack of Hepatic Stimulator Substance Expression Promotes Hepatocellular Carcinoma Metastasis Partly Through ERK-activated Epithelial–mesenchymal Transition

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2018English

JARID2 Promotes Invasion and Metastasis of Hepatocellular Carcinoma by Facilitating Epithelial-Mesenchymal Transition Through PTEN/AKT Signaling

Oncotarget
Oncology
2016English

LncRNA LOC105372579 Promotes Proliferation and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma via Activating miR-4316/FOXP4 Signaling

Cancer Management and Research
Oncology
2019English

SATB1 Promotes Epithelial-Mesenchymal Transition via Notch Signaling Pathway in Colorectal Cancer

European Journal of Inflammation
2019English

Spred2 Inhibits Epithelial‑mesenchymal Transition of Colorectal Cancer Cells by Impairing ERK Signaling

Oncology Reports
MedicineCancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy